Heme and iron metabolism: role in cerebral hemorrhage
KR Wagner, FR Sharp, TD Ardizzone… - Journal of Cerebral …, 2003 - journals.sagepub.com
Heme and iron metabolism are of considerable interest and importance in normal brain
function as well as in neurodegeneration and neuropathologically following traumatic injury …
function as well as in neurodegeneration and neuropathologically following traumatic injury …
Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought
RM Pluta, J Hansen-Schwartz, J Dreier… - Neurological …, 2009 - Taylor & Francis
Objective: Delayed cerebral vasospasm has long been recognized as an important cause of
poor outcome after an otherwise successful treatment of a ruptured intracranial aneurysm …
poor outcome after an otherwise successful treatment of a ruptured intracranial aneurysm …
Metastatic renal cell carcinoma
RC Flanigan, SC Campbell, JI Clark… - Current treatment options …, 2003 - Springer
Opinion statement Patients with renal cell cancer (RCC) develop metastatic spread in
approximately 33% of cases. The clinical management of patients with metastatic RCC is …
approximately 33% of cases. The clinical management of patients with metastatic RCC is …
[HTML][HTML] Improved survival with ipilimumab in patients with metastatic melanoma
FS Hodi, SJ O'day, DF McDermott… - … England Journal of …, 2010 - Mass Medical Soc
Background An improvement in overall survival among patients with metastatic melanoma
has been an elusive goal. In this phase 3 study, ipilimumab—which blocks cytotoxic T …
has been an elusive goal. In this phase 3 study, ipilimumab—which blocks cytotoxic T …
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer
B Almand, JI Clark, E Nikitina, J van Beynen… - The Journal of …, 2001 - journals.aai.org
Defective dendritic cell (DC) function caused by abnormal differentiation of these cells is an
important mechanism of tumor escape from immune system control. Previously, we have …
important mechanism of tumor escape from immune system control. Previously, we have …
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
K Margolin, MS Ernstoff, O Hamid, D Lawrence… - The lancet …, 2012 - thelancet.com
Background Brain metastases commonly develop in patients with melanoma and are a
frequent cause of death of patients with this disease. Ipilimumab improves survival in …
frequent cause of death of patients with this disease. Ipilimumab improves survival in …
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
CRISPR-Cas-mediated genome editing relies on guide RNAs that direct site-specific DNA
cleavage facilitated by the Cas endonuclease. Here we report that chemical alterations to …
cleavage facilitated by the Cas endonuclease. Here we report that chemical alterations to …
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
DF McDermott, MM Regan, JI Clark… - Journal of clinical …, 2005 - ascopubs.org
Purpose The Cytokine Working Group conducted a randomized phase III trial to determine
the value of outpatient interleukin-2 (IL-2) and interferon alfa-2b (IFN) relative to high-dose …
the value of outpatient interleukin-2 (IL-2) and interferon alfa-2b (IFN) relative to high-dose …
Clinical significance of defective dendritic cell differentiation in cancer
B Almand, JR Resser, B Lindman, S Nadaf… - Clinical Cancer …, 2000 - AACR
Defective dendritic cell (DC) function has been described previously in cancer patients and
tumor-bearing mice. It can be an important factor in the escape of tumors from immune …
tumor-bearing mice. It can be an important factor in the escape of tumors from immune …
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced …
R Haddad, A O'Neill, G Rabinowits, R Tishler… - The Lancet …, 2013 - thelancet.com
Background The relative efficacy of the addition of induction chemotherapy to
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …